GABRG2 Gene Dravet Syndrome NGS Genetic DNA Test
Comprehensive Genetic Testing for Severe Childhood Epilepsy
The GABRG2 Gene Dravet Syndrome NGS Genetic DNA Test represents a breakthrough in neurological genetic diagnostics, offering precise identification of mutations responsible for one of the most challenging forms of childhood epilepsy. Dravet syndrome, previously known as Severe Myoclonic Epilepsy of Infancy (SMEI), is a rare and catastrophic form of epilepsy that begins in infancy and persists throughout life. This advanced genetic test provides critical information for accurate diagnosis, prognosis, and personalized treatment planning.
What Does This Test Measure?
This sophisticated genetic analysis specifically targets the GABRG2 gene using Next-Generation Sequencing technology to detect:
- Pathogenic variants and mutations in the GABRG2 gene
- Single nucleotide polymorphisms (SNPs) associated with Dravet syndrome
- Copy number variations affecting GABA receptor function
- Novel genetic alterations impacting neuronal inhibition
Who Should Consider This Test?
This genetic test is recommended for individuals presenting with:
- Infants experiencing prolonged febrile seizures before 12 months
- Children with treatment-resistant epilepsy that doesn’t respond to conventional medications
- Patients showing developmental regression following seizure onset
- Family history of epilepsy or sudden unexplained death in epilepsy (SUDEP)
- Children with ataxia, cognitive impairment, or behavioral issues alongside seizures
- Patients with suspected genetic epilepsy syndromes
Key Benefits of GABRG2 Genetic Testing
- Early and Accurate Diagnosis: Provides definitive diagnosis when clinical symptoms are ambiguous
- Personalized Treatment Planning: Enables targeted therapeutic approaches based on genetic findings
- Family Planning Guidance: Offers crucial information for genetic counseling and reproductive decisions
- Prognostic Insights: Helps predict disease progression and potential complications
- Avoidance of Harmful Medications: Identifies patients who may have adverse reactions to specific anti-epileptic drugs
Understanding Your Test Results
Your genetic test results will be carefully interpreted by our team of board-certified genetic counselors and neurologists:
- Positive Result: Indicates the presence of a pathogenic GABRG2 mutation, confirming Dravet syndrome diagnosis
- Negative Result: Suggests absence of detectable GABRG2 mutations, though other genetic causes may be considered
- Variant of Uncertain Significance (VUS): Requires additional family studies and clinical correlation
- Carrier Status: Identifies individuals who carry the mutation but may not show symptoms
Test Pricing Information
| Price Type | Amount (USD) |
|---|---|
| Discount Price | $500 |
| Regular Price | $700 |
Nationwide Testing Availability
We proudly serve patients across the United States with convenient testing locations in all major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, Austin, Jacksonville, Fort Worth, Columbus, San Francisco, and many more. Our network of certified genetic testing facilities ensures accessible, reliable testing for families nationwide.
Take the Next Step Toward Clarity
Don’t let uncertainty about your child’s neurological condition continue. The GABRG2 Gene Dravet Syndrome NGS Genetic DNA Test provides the answers you need to make informed decisions about treatment and care. Our experienced genetic counselors are available to discuss your results and provide comprehensive guidance.
Call or WhatsApp us today at +1(267) 388-9828 to schedule your genetic testing appointment or to speak with our genetic counseling team. Take control of your neurological health with precise genetic insights from America’s leading genetics laboratory.
